Abstract
Trypanosoma cruzi, the causative agent of Chagas' disease, exhibits two different developmental stages in mammals, the amastigote, an intracellular form that proliferates in the cytoplasm of host cells, and the trypomastigote, an extracellular form that circulates in the bloodstream. We have already established an in vitro culture system using mammalian host cells (HeLa) infected with T. cruzi in which the time course of parasite growth is determined quantitatively. We adopted this system for the screening of anti-T. cruzi agents that would ideally prove to be effective against trypanosomes with no toxicity to the host cell. Of the purine analogs tested, allopurinol markedly inhibited the growth of amastigotes in a dose-dependent manner, with no lethal effect on trypomastigotes. 3'-Deoxyinosine and 3'-deoxyadenosine also suppressed T. cruzi growth inside the host cell, with the concentrations causing 50% growth inhibition being 10 and 5 microM, respectively, in contrast to a concentration causing 50% growth inhibition of 3 microM for allopurinol. Among the pyrimidine analogs examined, 3'-azido-3'-deoxythymidine (zidovudine) significantly reduced the growth of the parasite at concentrations as low as 1 microM. The anti-human immunodeficiency virus agents 2',3'-dideoxyinosine and 2',3'-dideoxyadenosine caused a decrease in amastigote growth, while 2',3'-dideoxycytidine and 2',3'-dideoxyuridine had no inhibitory effect. When Swiss 3T3 fibroblasts were used as host cells, allopurinol, 3'-deoxyinosine, 3'-deoxyadenosine, and 3'-azid-3'-deoxythymidine also markedly inhibited T. cruzi proliferation. These results indicate that our culture system is useful as a primary screening method for candidate compounds against T. cruzi on the basis of two criteria, namely, intracellular replication by the parasite and host-cell infection rate.
Full Text
The Full Text of this article is available as a PDF (199.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aoki T., Nakajima-Shimada J., Hirota Y. Quantitative determination of Trypanosoma cruzi growth inside host cells in vitro and effect of allopurinol. Adv Exp Med Biol. 1994;370:499–502. doi: 10.1007/978-1-4615-2584-4_105. [DOI] [PubMed] [Google Scholar]
- Brener Z. Biology of Trypanosoma cruzi. Annu Rev Microbiol. 1973;27:347–382. doi: 10.1146/annurev.mi.27.100173.002023. [DOI] [PubMed] [Google Scholar]
- Kaneda Y., Nagakura K., Goutsu T. Lipid composition of three morphological stages of Trypanosoma cruzi. Comp Biochem Physiol B. 1986;83(3):533–536. doi: 10.1016/0305-0491(86)90292-0. [DOI] [PubMed] [Google Scholar]
- Marr J. J., Berens R. L. Pyrazolopyrimidine metabolism in the pathogenic trypanosomatidae. Mol Biochem Parasitol. 1983 Apr;7(4):339–356. doi: 10.1016/0166-6851(83)90016-6. [DOI] [PubMed] [Google Scholar]
- Marr J. J. Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. J Lab Clin Med. 1991 Aug;118(2):111–119. [PubMed] [Google Scholar]
- Moorman A. R., LaFon S. W., Nelson D. J., Carter H. H., Marr J. J., Berens R. L. Antiprotozoal activity of 3'-deoxyinosine. Inverse correlation to cleavage of the glycosidic bond. Biochem Pharmacol. 1991 Jul 5;42(2):207–212. doi: 10.1016/0006-2952(91)90704-9. [DOI] [PubMed] [Google Scholar]
- Solari A., Tharaud D., Repetto Y., Aldunate J., Morello A., Litvak S. In vitro and in vivo studies of Trypanosoma cruzi DNA polymerase. Biochem Int. 1983 Aug;7(2):147–157. [PubMed] [Google Scholar]
- Suhadolnik R. J. Naturally occurring nucleoside and nucleotide antibiotics. Prog Nucleic Acid Res Mol Biol. 1979;22:193–291. doi: 10.1016/s0079-6603(08)60801-6. [DOI] [PubMed] [Google Scholar]
- TALIAFERRO W. H., PIZZI T. Connective tissue reactions in normal and immunized mice to a reticulotropic strain of Trypanosoma cruzi. J Infect Dis. 1955 May-Jun;96(3):199–226. doi: 10.1093/infdis/96.3.199. [DOI] [PubMed] [Google Scholar]
- Villanueva M. S., Williams S. P., Beard C. B., Richards F. F., Aksoy S. A new member of a family of site-specific retrotransposons is present in the spliced leader RNA genes of Trypanosoma cruzi. Mol Cell Biol. 1991 Dec;11(12):6139–6148. doi: 10.1128/mcb.11.12.6139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wataya Y., Hiraoka O. 3'-Deoxyinosine as an anti-leishmanial agent: the metabolism and cytotoxic effects of 3'-deoxyinosine in Leishmania tropica promastigotes. Biochem Biophys Res Commun. 1984 Sep 17;123(2):677–683. doi: 10.1016/0006-291x(84)90282-1. [DOI] [PubMed] [Google Scholar]
- Yarchoan R., Pluda J. M., Perno C. F., Mitsuya H., Thomas R. V., Wyvill K. M., Broder S. Initial clinical experience with dideoxynucleosides as single agents and in combination therapy. Ann N Y Acad Sci. 1990;616:328–343. doi: 10.1111/j.1749-6632.1990.tb17853.x. [DOI] [PubMed] [Google Scholar]
- de Souza W. Cell biology of Trypanosoma cruzi. Int Rev Cytol. 1984;86:197–283. doi: 10.1016/s0074-7696(08)60180-1. [DOI] [PubMed] [Google Scholar]